• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

轻链κ和λ在AL型淀粉样变性患者心脏功能评估中的作用

The Role of Light Kappa and Lambda Chains in Heart Function Assessment in Patients with AL Amyloidosis.

作者信息

Czyżewska Emilia, Wiśniewska Agnieszka, Waszczuk-Gajda Anna, Ciepiela Olga

机构信息

Department of Laboratory Medicine, Medical University of Warsaw, Banacha 1a, 02-097 Warsaw, Poland.

Department of Hematology, Oncology and Internal Diseases, Medical University of Warsaw, Banacha 1a, 02-097 Warsaw, Poland.

出版信息

J Clin Med. 2021 Mar 18;10(6):1274. doi: 10.3390/jcm10061274.

DOI:10.3390/jcm10061274
PMID:33803904
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8003288/
Abstract

There are reports indicating that myocardial dysfunction in systemic immunoglobulin light chain amyloidosis (AL amyloidosis) stems not only from the amyloid deposit in the organ but also the cardiotoxicity of the amyloid precursor free light chains (FLCs) circulating in the blood. The aim of the study is to analyze the role of sFLC κ and λ in the assessment of heart involvement and the degree of myocardial damage in AL amyloidosis. The study involved 71 patients diagnosed with primary AL amyloidosis. The relationship between sFLC concentrations and cardiac biochemical and echocardiographic parameters was assessed. The median concentrations of N-terminal pro b-type natriuretic peptide(NT-proBNP) and troponin I (TnI) were significantly higher in patients with amyloids formed from monoclonal λ chains compared to patients with monoclonal κ proliferation. In patients with heart involvement by amyloids formed from monoclonal FLC, the study demonstrated a statistically significant positive correlation between the concentration of monoclonal antibody λ chain and TnI (R = 0.688; < 0.05), NT-proBNP (R = 0.449; < 0.05), and the value of diastolic dimension of the interventricular septum (IVS; R = 0.496, < 0.05). The above data indicate that the presence of monoclonal λ chains in patients with AL amyloidosis may be associated with more severe damage to cardiomyocytes and dysfunction of the myocardium.

摘要

有报告表明,系统性免疫球蛋白轻链淀粉样变性(AL淀粉样变性)中的心肌功能障碍不仅源于器官中的淀粉样蛋白沉积,还源于血液中循环的淀粉样蛋白前体游离轻链(FLC)的心脏毒性。本研究的目的是分析可溶性FLC κ和λ在评估AL淀粉样变性中心脏受累情况及心肌损伤程度方面的作用。该研究纳入了71例诊断为原发性AL淀粉样变性的患者。评估了可溶性FLC浓度与心脏生化及超声心动图参数之间的关系。与单克隆κ增殖患者相比,由单克隆λ链形成淀粉样蛋白的患者中,N末端B型利钠肽原(NT-proBNP)和肌钙蛋白I(TnI)的中位浓度显著更高。在由单克隆FLC形成淀粉样蛋白而累及心脏的患者中,研究显示单克隆抗体λ链浓度与TnI(R = 0.688;P<0.05)、NT-proBNP(R = 0.449;P<0.05)以及室间隔舒张期内径值(IVS;R = 0.496,P<0.05)之间存在统计学显著正相关。上述数据表明,AL淀粉样变性患者中存在单克隆λ链可能与更严重的心肌细胞损伤和心肌功能障碍有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abe0/8003288/df7e5292f804/jcm-10-01274-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abe0/8003288/df7e5292f804/jcm-10-01274-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abe0/8003288/df7e5292f804/jcm-10-01274-g001.jpg

相似文献

1
The Role of Light Kappa and Lambda Chains in Heart Function Assessment in Patients with AL Amyloidosis.轻链κ和λ在AL型淀粉样变性患者心脏功能评估中的作用
J Clin Med. 2021 Mar 18;10(6):1274. doi: 10.3390/jcm10061274.
2
The Influence of Deterioration of Kidney Function on the Diagnostic Power of Laboratory Parameters Used in the Prognostic Classification of AL Amyloidosis.肾功能恶化对用于AL淀粉样变性预后分类的实验室参数诊断效能的影响。
J Clin Med. 2021 Oct 24;10(21):4903. doi: 10.3390/jcm10214903.
3
Amino acid sequence homology of monoclonal serum free light chain dimers and tissue deposited light chains in AL amyloidosis: a pilot study.在 AL 淀粉样变性中单克隆无血清轻链二聚体和组织沉积轻链的氨基酸序列同源性:一项初步研究。
Clin Chem Lab Med. 2023 Sep 26;62(3):464-471. doi: 10.1515/cclm-2023-0591. Print 2024 Feb 26.
4
Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains.游离κ和游离λ免疫球蛋白轻链的血清参考区间及诊断范围:检测单克隆轻链的相对敏感性
Clin Chem. 2002 Sep;48(9):1437-44.
5
A patient with AL amyloidosis with negative free light chain results.一位有 AL 淀粉样变性且游离轻链检测结果为阴性的患者。
Clin Chem Lab Med. 2016 Jun 1;54(6):1035-7. doi: 10.1515/cclm-2015-0847.
6
[The clinical significance of serum free light chain in primary systemic amyloidosis].[血清游离轻链在原发性系统性淀粉样变中的临床意义]
Zhonghua Nei Ke Za Zhi. 2011 May;50(5):404-7.
7
Right Heart Changes Impact on Clinical Phenotype of Amyloid Cardiac Involvement: A Single Centre Study.右心改变对心脏淀粉样变临床表型的影响:一项单中心研究
Life (Basel). 2020 Oct 18;10(10):247. doi: 10.3390/life10100247.
8
Prognosis of Light Chain Amyloidosis With Preserved LVEF: Added Value of 2D Speckle-Tracking Echocardiography to the Current Prognostic Staging System.二维斑点追踪超声心动图对左心室射血分数保留型轻链型淀粉样变性患者预后的评估:对现行预后分期系统的补充价值。
JACC Cardiovasc Imaging. 2017 Apr;10(4):398-407. doi: 10.1016/j.jcmg.2016.04.008. Epub 2016 Sep 14.
9
Serum immunoglobulin free light-chain measurement in primary amyloidosis: prognostic value and correlations with clinical features.原发性淀粉样变中单克隆免疫球蛋白游离轻链的检测:预后价值及其与临床特征的相关性。
Blood. 2010 Dec 9;116(24):5126-9. doi: 10.1182/blood-2010-06-290668. Epub 2010 Aug 26.
10
[The prognostic value of baseline serum free light chain in cardiac amyloidosis].[基线血清游离轻链在心脏淀粉样变性中的预后价值]
Zhonghua Nei Ke Za Zhi. 2016 Mar;55(3):186-90. doi: 10.3760/cma.j.issn.0578-1426.2016.03.006.

引用本文的文献

1
The Prognostic Value of Platelet-to-Lymphocyte Ratio and Tricuspid Regurgitation Velocity in Patients with Light-Chain Myocardial Amyloidosis.血小板与淋巴细胞比值及三尖瓣反流速度在轻链型心肌淀粉样变患者中的预后价值
J Inflamm Res. 2025 Jul 3;18:8787-8804. doi: 10.2147/JIR.S520998. eCollection 2025.
2
Cardiac Troponin in Patients With Light Chain and Transthyretin Cardiac Amyloidosis: State-of-the-Art Review.轻链和转甲状腺素蛋白型心脏淀粉样变患者的心肌肌钙蛋白:最新综述
JACC CardioOncol. 2024 Feb 20;6(1):1-15. doi: 10.1016/j.jaccao.2023.12.006. eCollection 2024 Feb.
3
Free Light Chains and as New Biomarkers of Selected Diseases.

本文引用的文献

1
The clinical features and outcomes of systemic AL amyloidosis: a cohort of 231 Chinese patients.系统性 AL 淀粉样变的临床特征和结局:231 例中国患者的队列研究。
Clin Kidney J. 2015 Feb;8(1):120-6. doi: 10.1093/ckj/sfu117. Epub 2014 Nov 13.
2
[Progress in the diagnosis and treatment of cardiac amyloidosis].[心脏淀粉样变性的诊断与治疗进展]
Przegl Lek. 2014;71(6):340-5.
3
[Light chain amyloidosis--clinical symptoms, update diagnosis, and treatment].[轻链型淀粉样变性——临床症状、最新诊断与治疗]
游离轻链及其作为某些疾病新型生物标志物的应用。
Int J Mol Sci. 2023 May 31;24(11):9531. doi: 10.3390/ijms24119531.
4
The Influence of Deterioration of Kidney Function on the Diagnostic Power of Laboratory Parameters Used in the Prognostic Classification of AL Amyloidosis.肾功能恶化对用于AL淀粉样变性预后分类的实验室参数诊断效能的影响。
J Clin Med. 2021 Oct 24;10(21):4903. doi: 10.3390/jcm10214903.
Przegl Lek. 2014;71(2):102-9.
4
High sensitivity cardiac troponin T in patients with immunoglobulin light chain amyloidosis.免疫球蛋白轻链淀粉样变性患者的高敏心肌肌钙蛋白 T。
Heart. 2014 Mar;100(5):383-8. doi: 10.1136/heartjnl-2013-304957. Epub 2014 Jan 8.
5
Incidence, diagnosis and prognosis of cardiac amyloidosis.心脏淀粉样变性的发病、诊断和预后。
Korean Circ J. 2013 Nov;43(11):752-60. doi: 10.4070/kcj.2013.43.11.752. Epub 2013 Nov 30.
6
Al amyloidosis.淀粉样变。
Orphanet J Rare Dis. 2012 Aug 21;7:54. doi: 10.1186/1750-1172-7-54.
7
What do I need to know about immunoglobulin light chain (AL) amyloidosis?我需要了解免疫球蛋白轻链(AL)淀粉样变性的哪些知识?
Blood Rev. 2012 Jul;26(4):137-54. doi: 10.1016/j.blre.2012.03.001. Epub 2012 Apr 25.
8
Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements.改良的轻链淀粉样变预后分期系统,纳入了心脏生物标志物和血清游离轻链检测。
J Clin Oncol. 2012 Mar 20;30(9):989-95. doi: 10.1200/JCO.2011.38.5724. Epub 2012 Feb 13.
9
Current perspectives on cardiac amyloidosis.当前对心脏淀粉样变性的认识。
Am J Physiol Heart Circ Physiol. 2012 Feb 1;302(3):H544-52. doi: 10.1152/ajpheart.00815.2011. Epub 2011 Nov 4.
10
Cytotoxicity of amyloidogenic immunoglobulin light chains in cell culture.免疫球蛋白轻链淀粉样变在细胞培养中的细胞毒性
Cell Death Dis. 2010 Nov 11;1(11):e98. doi: 10.1038/cddis.2010.75.